EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Moyamoya Vasculopathy in Neurofibromatosis Type 1 Pediatric Patients: The Role of Rare Variants of RNF213

Marzia Ognibene iD, Marcello Scala iD, Michele Iacomino, Irene Schiavetti iD, Francesca Madia iD, Monica Traverso, Sara Guerrisi, Marco Di Duca, Francesco Caroli iD, Simona Baldassari iD, Barbara Tappino iD, Ferruccio Romano und 9 weitere

Cancers · 22.03.2023 · 15 (6) · 1916

DOI: 10.3390/cancers15061916 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 22.03.2023. Verfasst von Marzia Ognibene und 20 weiteren Autor:innen. Beteiligte Einrichtung: U.O.C. Genetica Medica, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Health Ministry, Italain Health Ministry, Finanziamento.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurofibromatosis type 1 (NF1) is a neurocutaneous disorder caused by mutations in NF1 gene, coding for neurofibromin 1. NF1 can be associated with Moyamoya disease (MMD), and this association, typical of paediatric patients, is referred to as Moyamoya syndrome (MMS). MMD is a cerebral arteriopathy characterized by the occlusion of intracranial arteries and collateral vessel formation, which increase the risk of ischemic and hemorrhagic events. RNF213 gene mutations have been associated with MMD, so we investigated whether rare variants of RNF213 could act as genetic modifiers of MMS phenotype in a pediatric cohort of 20 MMS children, 25 children affected by isolated MMD and 47 affected only by isolated NF1. By next-generation re-sequencing (NGS) of patients’ DNA and gene burden tests, we found that RNF213 seems to play a role only for MMD occurrence, while it does not appear to be involved in the increased risk of Moyamoya for MMS patients. We postulated that the loss of neurofibromin 1 can be enough for the excessive proliferation of vascular smooth muscle cells, causing Moyamoya arteriopathy associated with NF1. Further studies will be crucial to support these findings and to elucidate the possible role of other genes, enhancing our knowledge about pathogenesis and treatment of MMS.

Schlagwörter

Stichwörter der Autor:innen

MoyamoyaNF1RNF213neurofibromatosis type 1next-generation sequencing (NGS)

Autor:innen und Institutionen

  • U.O.C. Genetica Medica, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.
  • Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, Università Degli Studi di Genova, 16145 Genova, Italy.
  • Dipartimento di Scienze della Salute, Università di Genova, 16132 Genova, Italy.
  • U.O.C. Neurologia Pediatrica e Malattie Muscolari, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.
  • LABSIEM (Laboratory for the Study of Inborn Errors of Metabolism), IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.
  • U.O.C. Genomica e Genetica Clinica, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.

ORCID-Profile: Marzia Ognibene, Marcello Scala, Irene Schiavetti, Francesca Madia, Francesco Caroli, Simona Baldassari, Barbara Tappino, Paolo Uva, Cristina Chelleri, Maria Cristina Diana, Marco Pavanello, Patrizia De Marco

Förderung

  • Italian Health Ministry
  • Italain Health Ministry
  • Finanziamento

Zitieren

APA

Ognibene, M., Scala, M., Iacomino, M., Schiavetti, I., Madia, F., Traverso, M., Guerrisi, S., Di Duca, M., Caroli, F., Baldassari, S., Tappino, B., Romano, F., Uva, P., Vozzi, D., Chelleri, C., Piatelli, G., Diana, M. C., Zara, F., Capra, V., …, & De Marco, P. (2023). Moyamoya Vasculopathy in Neurofibromatosis Type 1 Pediatric Patients: The Role of Rare Variants of RNF213. Cancers, 15(6), 1916. https://doi.org/10.3390/cancers15061916

Vancouver

Ognibene M, Scala M, Iacomino M, Schiavetti I, Madia F, Traverso M, et al. Moyamoya Vasculopathy in Neurofibromatosis Type 1 Pediatric Patients: The Role of Rare Variants of RNF213. Cancers. 2023;15(6):1916. doi:10.3390/cancers15061916

BibTeX
@article{Ognibene2023,
  author = {Ognibene, Marzia and Scala, Marcello and Iacomino, Michele and Schiavetti, Irene and Madia, Francesca and Traverso, Monica and Guerrisi, Sara and Di Duca, Marco and Caroli, Francesco and Baldassari, Simona and Tappino, Barbara and Romano, Ferruccio and Uva, Paolo and Vozzi, Diego and Chelleri, Cristina and Piatelli, Gianluca and Diana, Maria Cristina and Zara, Federico and Capra, Valeria and Pavanello, Marco and De Marco, Patrizia},
  title = {Moyamoya Vasculopathy in Neurofibromatosis Type 1 Pediatric Patients: The Role of Rare Variants of RNF213},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {6},
  pages = {1916},
  doi = {10.3390/cancers15061916}
}
Kostenlos starten →